Shopping Cart
- Remove All
- Your shopping cart is currently empty
(E/Z)-Teriflunomide (Aubagio), a orally-available Pyrimidine Synthesis Inhibitor, is used to treat relapsing multiple sclerosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
50 mg | $31 | In Stock | |
100 mg | $48 | In Stock | |
1 mL x 10 mM (in DMSO) | $29 | In Stock |
Description | (E/Z)-Teriflunomide (Aubagio), a orally-available Pyrimidine Synthesis Inhibitor, is used to treat relapsing multiple sclerosis. |
In vitro | In animal models of demyelinating diseases, Teriflunomide has demonstrated efficacy. For instance, in the black rat model of autoimmune encephalomyelitis, Teriflunomide has shown both preventive and therapeutic effects; similarly, in female Lewis rat models of Experimental Autoimmune Encephalomyelitis (EAE), it has been effective in ameliorating symptoms and reducing disease exacerbation. |
In vivo | Teriflunomide acts as a dihydroorotate dehydrogenase inhibitor, thereby inhibiting the de novo synthesis of pyrimidine in rapidly proliferating cells. By suppressing highly proliferative T and B lymphocytes, Teriflunomide effectively reduces the inflammatory response to self-antigens. |
Alias | HMR-1726, Flucyamide, Aubagio, A77 1726 |
Molecular Weight | 270.21 |
Formula | C12H9F3N2O2 |
Cas No. | 108605-62-5 |
Smiles | N#CC(C(=O)NC1=CC=C(C=C1)C(F)(F)F)=C(O)C |
Relative Density. | 1.424 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 6.25 mg/mL (23.13 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.